This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignees: The University of Queensland, Trinity College Dublin. Active years: 2023-2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:


Years Active: 2023-2024
Title: Innovations of Angus Murray MacLeod
Introduction
Angus Murray MacLeod is a notable inventor based in Cambridge, GB. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative patents. With a total of two patents to his name, MacLeod's work focuses on compounds that have potential therapeutic applications.
Latest Patents
MacLeod's latest patents include "Sulfonylureas and related compounds and use of same." This invention relates to compounds of a specific formula, which includes various elements such as O, S, and Se. The compounds are designed for pharmaceutical applications, particularly in treating NLRP3 inflammasome mediated disorders. Another patent focuses on compounds that stimulate insulin secretion while inhibiting NLRP3, showcasing his dual-action approach to medical treatment.
Career Highlights
Throughout his career, MacLeod has worked with prestigious institutions, including the University of Queensland. His research has contributed to advancements in medical science, particularly in the development of new pharmaceutical compositions. His innovative work has garnered attention in the scientific community.
Collaborations
MacLeod has collaborated with notable figures in the field, including Luke O'Neill and Rebecca Coll. These partnerships have likely enhanced the scope and impact of his research, leading to significant advancements in pharmaceutical innovations.
Conclusion
Angus Murray MacLeod's contributions to the field of pharmaceuticals through his patents demonstrate his commitment to advancing medical science. His innovative compounds hold promise for treating various medical disorders, showcasing the importance of research and collaboration in the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile